![Moderna testing mRNA flu vaccine in clinical trial](https://static.foxnews.com/foxnews.com/content/uploads/2021/07/band_aid_istock.jpg)
Moderna testing mRNA flu vaccine in clinical trial
Fox News
Moderna has begun testing an mRNA flu vaccine in clinical trials, with the company announcing Wednesday that the first participants had been dosed in the Phase 1/2 study.
"We are pleased to have begun this Phase 1/2 study of mRNA-1010, our first mRNA seasonal flu vaccine candidate to enter the clinic," Stephane Bancel, Moderna’s CEO, said in a news release. "Respiratory combination vaccines are an important pillar of our overall mRNA vaccine strategy. We believe that the advantages of mRNA vaccines include the ability to combine different antigens to protect against multiple viruses and the ability to rapidly respond to the evaluation of respiratory viruses, such as influenza, SARS-CoV-2 and RSV." Traditionally, annual influenza vaccines see efficacy of between 40-60%, but the new mRNA-based COVID-19 shots saw rates upwards of 90%. Moderna’s COVID-19 jab, specifically, saw 94.1% efficacy in those who had received two doses.More Related News